Chris Fraley

By Chris Fraley, InvestorPlace Contributor Feb 28, 2017

Twilio (TWLO) stock has yet to recover from its October and November decline. Here's why a breakout is inevitable.

By Chris Fraley, InvestorPlace Contributor Feb 23, 2017

Valeant has lost nearly all its value in the last 18 months due to its involvement with a drug called Siliq -- can it also save VRX stock?

By Chris Fraley, InvestorPlace Contributor Feb 15, 2017

Microsoft (MSFT) has a potentially revolutionary new operating system in the works. But investors may need to see more before buying in.

By Chris Fraley, InvestorPlace Contributor Feb 6, 2017

Exxon Mobil just reported its worst quarterly earnings results in 17 years, but the damage to XOM stock has been limited. Is it time to buy?

By Chris Fraley, InvestorPlace Contributor Feb 1, 2017

Biogen just beat fourth-quarter earnings. But BIIB stock won't really get going until the biotech sector as a whole does.

Recent Articles